Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation of the 2007 Annual Meeting of AHRQ

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Evidence Impacts in the Model

Text Description is below the image.


  • Available Evidence
    • Rate of Eye exams
    • Rate of Microalbuminuria Screening
    • Rate of Foot Exams
    • Change in Systolic BP
    • Change in Cholesterol
    • Change In HbA1c
  • Complications
    • No retinopathy to Photocoagulation to Blindness
    • No Nephropathy to Microalbuminuria to Nephropathy to ESRD to Death
    • No Neuropathy to Peripheral Neuropathy to LEA to Hx LEA to Repeat LEA to Death
    • Foot ulcer rates
    • No stroke to Stroke to Stroke Death
    • No CHD to Angina to CA/MI to CHD Death
    • HTN
    • SBP
    • LVH


Note: highlight this is where management of diabetes impacts complications in our model.

Transition to next slide: This is where we are able to show value of ITDM.

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care